Ysios Capital

Ysios Capital Partners, SGEIC, S.A.U. is a private equity and venture capital firm founded in 2008, based in Donostia-San Sebastián, Spain, with additional offices in Europe and North America. The firm specializes in seed and early-stage investments, focusing on human healthcare innovations, life sciences, biotechnology, and digital health sectors, particularly in pharmaceuticals, diagnostics, and medical devices. Ysios Capital aims to support the development of therapeutic and diagnostic products, investing between €1.22 million and €22.69 million in promising companies. The firm typically seeks to take a board seat in its portfolio companies and holds investments for four to six years, with exit strategies involving public offerings or mergers and acquisitions. With over €200 million in assets under management through its two funds, Ysios Capital emphasizes transforming scientific knowledge into successful businesses while targeting regions across North America and Europe.